Verve Therapeutics, Inc. Profile Avatar - Palmy Investing

Verve Therapeutics, Inc.

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off …

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of VERV's Analysis
CIK: 1840574 CUSIP: 92539P101 ISIN: US92539P1012 LEI: - UEI: -
Secondary Listings
VERV has no secondary listings inside our databases.